⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 28, 2026International Journal of Cancer Care and DeliveryOpen Access

A Single-Center Analysis of Pathologic and Clinical Features, Treatment, and Outcomes in Post-Transplant Lymphoproliferative Disorder (PTLD)

Elisa De Togni Connor Hartzell Emily Mason Brian Hoeynck Shakthi Bhaskar Vivek Patel

View Full Paper

Ask AI

Bookmark

Share

Abstract

BackgroundPTLD is a rare heterogenous group of lymphoproliferative diseases arising from chronic immunosuppression after solid organ or allogeneic stem cell transplantation (allo-SCT).Treatment of PTLD involves a sequential approach with immunosuppression reduction and chemoimmunotherapy.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Togni et al. (2026) studied this question.

synapsesocial.com/papers/6abdf79466f3754618514615 https://doi.org/10.53876/001a.129857

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Posttransplant lymphoproliferative disorders following hematopoietic stem cell transplantation: a clinicopathological study of a large single-center cohortOriginal Research · 2026
2#99 Clinical characteristics and outcomes of PTLD after kidney transplant: a single center experience2024
3Admissions for posttransplant lymphoproliferative disorder: a 9-year longitudinal analysis of the National (Nationwide) Inpatient Sample2024
4Monomorphic post-transplant lymphoproliferative disorder with plasmablastic differentiation: a challenge for diagnosis and treatment2024
5Frequency, Characteristics, Management, and Outcomes of Posttransplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Multicentre Retrospective Study of the Turkish Pediatric BMT Study GroupCohort Study · 2026